Direct Binding of Integrin αvβ3 to FGF1 Plays a Role in FGF1 Signaling*

Integrins play a role in fibroblast growth factor (FGF) signaling through cross-talk with FGF receptors (FGFRs), but the mechanism underlying the cross-talk is unknown. We discovered that FGF1 directly bound to soluble and cell-surface integrin αvβ3 (KD about 1 μm). Antagonists to αvβ3 (monoclonal antibody 7E3 and cyclic RGDfV) blocked this interaction. αvβ3 was the predominant, if not the only, integrin that bound to FGF1, because FGF1 bound only weakly to several β1 integrins tested. We presented evidence that the CYDMKTTC sequence (the specificity loop) within the ligand-binding site of β3 plays a role in FGF1 binding. We found that the integrin-binding site of FGF1 overlaps with the heparin-binding site but is distinct from the FGFR-binding site using docking simulation and mutagenesis. We identified an FGF1 mutant (R50E) that was defective in integrin binding but still bound to heparin and FGFR. R50E was defective in inducing DNA synthesis, cell proliferation, cell migration, and chemotaxis, suggesting that the direct integrin binding to FGF1 is critical for FGF signaling. Nevertheless, R50E induced phosphorylation of FGFR1 and FRS2α and activation of AKT and ERK1/2. These results suggest that the defect in R50E in FGF signaling is not in the initial activation of FGF signaling pathway components, but in the later steps in FGF signaling. We propose that R50E is a useful tool to identify the role of integrins in FGF signaling.

[1]  D. Cheresh,et al.  Adhesion events in angiogenesis. , 2001, Current opinion in cell biology.

[2]  V. P. Eswarakumar,et al.  Cellular signaling by fibroblast growth factor receptors. , 2005, Cytokine & growth factor reviews.

[3]  J. Norman,et al.  αvβ3 and α5β1 integrin recycling pathways dictate downstream Rho kinase signaling to regulate persistent cell migration , 2007, The Journal of cell biology.

[4]  A. Sahni,et al.  FGF‐2 but not FGF‐1 binds fibrin and supports prolonged endothelial cell growth , 2003, Journal of thrombosis and haemostasis : JTH.

[5]  A. Khorana,et al.  FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis. , 2006, Blood.

[6]  P. Dell’Era,et al.  Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. , 2005, Cytokine & growth factor reviews.

[7]  A. Sahni,et al.  Stimulation of endothelial cell proliferation by FGF-2 in the presence of fibrinogen requires αvβ3 , 2004 .

[8]  P. Dell’Era,et al.  Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts , 2002, Oncogene.

[9]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[10]  X. Zhan,et al.  Src is required for cell migration and shape changes induced by fibroblast growth factor 1 , 1999, Oncogene.

[11]  M. Ittmann,et al.  The role of fibroblast growth factors and their receptors in prostate cancer. , 2004, Endocrine-related cancer.

[12]  E. Paleolog.  Angiogenesis in rheumatoid arthritis , 2002, Arthritis research.

[13]  P. Klint,et al.  Signal transduction by fibroblast growth factor receptors. , 1999, Frontiers in bioscience : a journal and virtual library.

[14]  Jeffrey W. Smith,et al.  The Cell Adhesion Domain in Plasma Vitronectin Is Cryptic* , 1997, The Journal of Biological Chemistry.

[15]  Y. Takada,et al.  Human Parechovirus 1 Utilizes Integrins αvβ3 and αvβ1 as Receptors , 2000, Journal of Virology.

[16]  Integrin αvβ3 Requirement for Sustained Mitogen-activated Protein Kinase Activity during Angiogenesis , 1998 .

[17]  Y. Takada,et al.  Non-cytotoxic cobra cardiotoxin A5 binds to alpha(v)beta3 integrin and inhibits bone resorption. Identification of cardiotoxins as non-RGD integrin-binding proteins of the Ly-6 family. , 2006, The Journal of biological chemistry.

[18]  R L Juliano,et al.  Integrin regulation of cell signalling and motility. , 2004, Biochemical Society transactions.

[19]  R. Friesel,et al.  Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  R. Timpl,et al.  Arg‐Gly‐Asp constrained within cyclic pentapoptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1 , 1991, FEBS letters.

[21]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[22]  C. Powers,et al.  Fibroblast growth factors, their receptors and signaling. , 2000, Endocrine-related cancer.

[23]  Neil J. Sebire,et al.  FGF‐2 protects small cell lung cancer cells from apoptosis through a complex involving PKCε, B‐Raf and S6K2 , 2006 .

[24]  C. Dickson,et al.  Fibroblast growth factor signaling in tumorigenesis. , 2005, Cytokine & growth factor reviews.

[25]  Garrett M. Morris,et al.  Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design , 2001, Science.

[26]  E. Brown,et al.  Integrin alpha v beta 3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor alpha 5 beta 1 , 1994, The Journal of cell biology.

[27]  K. Ramnarayan,et al.  Analysis of high-affinity binding determinants in the receptor binding epitope of basic fibroblast growth factor. , 1997, Protein engineering.

[28]  Y. Takada,et al.  Specific binding of integrin αvβ3 to the fibrinogen γ and α(E) chain C-terminal domains , 1999 .

[29]  S. Rafii,et al.  Activation of FGFR1β signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells , 2006, Leukemia.

[30]  Y. Takada,et al.  Rotavirus-neutralizing antibodies inhibit virus binding to integrins α2β1 and α4β1 , 2007, Archives of Virology.

[31]  D. Woods,et al.  Induction of β3-Integrin Gene Expression by Sustained Activation of the Ras-Regulated Raf–MEK–Extracellular Signal-Regulated Kinase Signaling Pathway , 2001, Molecular and Cellular Biology.

[32]  J. Takagi,et al.  Changing Ligand Specificities of αvβ1 and αvβ3 Integrins by Swapping a Short Diverse Sequence of the β Subunit* , 1997, The Journal of Biological Chemistry.

[33]  Timothy A. Springer,et al.  Therapeutic antagonists and conformational regulation of integrin function , 2003, Nature Reviews Drug Discovery.

[34]  J. Takagi,et al.  Integrin beta3 regions controlling binding of murine mAb 7E3: implications for the mechanism of integrin alphaIIbbeta3 activation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[35]  B. Thisse,et al.  Functions and regulations of fibroblast growth factor signaling during embryonic development. , 2005, Developmental biology.

[36]  A. Sharrocks.  Cell Cycle: Sustained ERK Signalling Represses the Inhibitors , 2006, Current Biology.

[37]  T. Maciag,et al.  Activation of the MAP Kinase Pathway by FGF-1 Correlates with Cell Proliferation Induction While Activation of the Src Pathway Correlates with Migration , 1998, The Journal of cell biology.

[38]  Harold P. Erickson,et al.  C-terminal opening mimics 'inside-out' activation of integrin α5β1 , 2001, Nature Structural Biology.

[39]  N. Sebire,et al.  FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2. , 2006, The EMBO journal.

[40]  Y. Takada,et al.  Multiple Discontinuous Ligand-mimetic Antibody Binding Sites Define a Ligand Binding Pocket in Integrin αIIbβ3 * , 2000, The Journal of Biological Chemistry.

[41]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[42]  Marco Presta,et al.  αvβ3 Integrin Mediates the Cell-adhesive Capacity and Biological Activity of Basic Fibroblast Growth Factor (FGF-2) in Cultured Endothelial Cells , 1997 .

[43]  C. MacArthur,et al.  Receptor Specificity of the Fibroblast Growth Factor Family* , 1996, The Journal of Biological Chemistry.

[44]  Shaun K Olsen,et al.  Receptor Specificity of the Fibroblast Growth Factor Family , 2006, Journal of Biological Chemistry.

[45]  D. Cheresh,et al.  Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels , 1994, Cell.

[46]  J. Au,et al.  Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  David F. Burke,et al.  Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin , 2000, Nature.

[48]  T. Ugarova,et al.  Regulated Unmasking of the Cryptic Binding Site for Integrin αMβ2 in the γC-Domain of Fibrinogen† , 2002 .

[49]  Joseph Schlessinger,et al.  Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand-Receptor Specificity , 2000, Cell.

[50]  R. Cattaneo,et al.  Anti-Ro/SSA antibodies in systemic sclerosis (SSc): determination of the fine specificity, clinical and laboratory correlations , 2002, Arthritis Research.

[51]  M. Schwartz,et al.  Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. , 2001, Journal of cell science.

[52]  W. Wang,et al.  Two-stage PCR protocol allowing introduction of multiple mutations, deletions and insertions using QuikChange Site-Directed Mutagenesis. , 1999, BioTechniques.

[53]  A. Ljubimov,et al.  Proteolysis regulates exposure of the IIICS-1 adhesive sequence in plasma fibronectin. , 1996, Biochemistry.

[54]  Y. Takada,et al.  The COOH-Terminal Globular Domain of Fibrinogen γ Chain Suppresses Angiogenesis and Tumor Growth , 2006 .

[55]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[56]  J. Au,et al.  Expression of Basic Fibroblast Growth Factor Correlates with Resistance to Paclitaxel in Human Patient Tumors , 2006, Pharmaceutical Research.